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BACKGROUND: Patients with endomyocardial fibrosis (EMF) characteristically present with gross ascites and absent or 
minimal pedal oedema. This has long puzzled clinicians, especially since this clinical picture remains the same regardless 
of whether there is left, right or biventricular ventricular heart failure. The development of ascites, therefore, may not 
be directly and solely related to changes in the heart, but to local changes in the peritoneum. In order to investigate this 
possibility we performed peritoneal biopsies on 28 EMF patients.
METHODS: Successful peritoneal biopsies were performed on 28 EMF patients and 11 age-matched healthy controls who 
had died in road accidents.
RESULTS: All 28 patients (100%) showed complete or partial peritoneal fibrosis. Twenty Six (93%) had additional signs of 
chronic peritonitis characterised mainly by lymphocytes (92%) eosinophils (27%) and plasma cells (23%). Neutrophils were 
not seen. Vascularisation was common (87%) with an increase in capillaries and granulation tissue. Other components were 
Russel bodies (50%), deposits of fibrin (50%) and haemosiderin pigment (32%). Only two samples showed fibrosis without 
signs of inflammation. None of the controls showed any of these changes. 
CONCLUSION: Peritoneal fibrosis was found in all and peritonitis in most of our EMF patients. This suggests that pathology 
of EMF is not confined to the heart but also involves the peritoneum. This local peritoneal inflammation may explain why 
marked ascites is often present with little or no peripheral oedema, and why conventional heart failure treatment is of 
limited value.
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Introduction 
Although rare elsewhere EMF is a common heart 
disease in certain geographical clusters such as in Uganda, 
Mozambique, Nigeria, Ivory Coast, Kerala (India) and 
Brazil. In Uganda it is associated with eosinophilia and 
poverty, females are twice as often affected compared to 
males and show a bimodal age distribution with peaks at 
around 12 and 27 years [1, 2] and can account for up 
to 20% of patients seen with cardiovascular diseases [3]. 
Fibrotic lesions of varying severity occur in one or both 
ventricles. Five patterns have been observed on autopsy: 
1. Affecting atrio-ventricular (AV) valves  causing 
mitral or tricuspid incompetence 
2. Affecting the only the apex causing restriction of 
ventricular filling. 
3. Affecting AV-valves and apex leading to both of 
the above. 
4. Stretching from AV- valve to apex with the same 
symptoms. 
5. Patchy fibrosis which is rare. 
Right and bi-ventricular EMF leads to a distortion 
of the cardiac shape with retraction of the right ventricle 
appearing as a notch on echocardiography. The 
characteristic clinical features are gross ascites with little or 
no pedal oedema (see Figure 1a and 1b) and may appear 
even before signs and symptoms of cardiac disease. Often 
the abdomen is painful on palpation. Other EMF typical 
features are hepatosplenomegaly (see Figure 1c), raised 
jugular venous pressure (see Figure 2) and proptosis. Up 
to 75% of patients show an eosinophilia with abnormal 
eosinophils [1] and the ascites is usually (78%) an exudate 
[4]. The typical socio-economic history includes poverty, 
unbalanced diet with high tuber consumption and severe 
lack of protein, especially animal protein. There are 
geographical predilection sites for EMF in Uganda and 
EMF with patients being predominantly of Rwandan or 
Bagandan origin. 
Some textbooks attribute the symptoms of EMF to the 
degree of fibrosis and its laterality in the heart - fibrosis of 
the right ventricle being associated with ascites and pedal 
oedema, and fibrosis of the left ventricle with pulmonary 
congestion. Hurst’s “The Heart”13th Edition 2011 [5] 
and the older version of Harrison’s Principles of Internal 
Medicine of 2003 [6] whereas in the latest 19th Edition 
2015 the symptoms are not described explicitly. However, 
ascites, often with abdominal pain and minimal or absent 
pedal oedema is the most common feature of EMF 
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Table 1. Frequency and density of inflammatory cells 
seen in peritoneal biopsies from 26 EMF patients 
Cell type Frequency Density
n % mild moderate marked
Lymphocytes 24 92 15 2 1
Eosinophils 7 27 6 1 -
Plasma cells 6 23 5 1 -
irrespective of which ventricle is involved, and gross ascites 
can be present even when fibrosis is entirely confined 
to the left ventricle [7]. Moreover, the ascites of EMF-
patients is protein rich and has higher white blood cell 
counts than ascites from patients with congestive cardiac 
failure [8, 4]. In order to determine if this exudative ascitic 
fluid was a result of inflammation, or some other process, 
peritoneal biopsies from both EMF patients and healthy 
controls were examined. Some cases of EMF are shown in 
Figures 1 and 2.
Methods
Twenty-eight patients between the age-groups of 10 
and 50 years old with a diagnosis of EMF were enrolled 
in the study. The diagnosis of EMF was based on clinical 
and echocardiographical observations by two independent 
cardiologists. To make a diagnosis of EMF combinations 
of the above mentioned clinical, paraclinical and 
echocardiographical criteria were used (socio-economic 
history, eosinophilia, exudative ascites and the typical 
echocardiographic features as described above).  
Peritoneal tissue was obtained by an aseptic technique 
using an Abram’s needle in all patients with frank ascites 
and in two other patients with abdominal swelling 
without ascites by a mini-laparatomy [9]. Control biopsy 
specimens were taken from eleven age-matched previously 
healthy persons who had died from road traffic accidents.
The design of the study did not allow us to take 
pericardial or pleurabiopsies although pericardial effusion 
and to a lesser extend pleura effusion were seen.
Results
Inventory of cases 
Twenty-eight patients were studied. There was a male 
to female ratio of 1:3.3. Males tended to be younger. 
The mean age for males was 18.8 years (range 11 – 25 
years) and for females 25.6 years (range 14 – 41 years). 
Duration of symptoms varied between 10 days to 182 
months.  Blood values in means (and range) were ESR 38 
(5-110) mm in the first hour by the Westergren method; 
total white cell count 4,900 (3,500-7,900) cells/mm3, 
eosinophil count 640 (40-2240) cells/mm3. Fifteen 
patients (42%) showed eosinophilia with more than 
500 cells/mm3 including 4 patients (9%) in the range of 
the hypereosinophilic syndrome with more than 1,500 
cells/mm3. Serum protein was 6.2 (2.8-9.9) g/dl, serum 
albumin 3.0 (0.2-4.3) g/dl. 
Half of the patients showed biventricular EMF, 
30% only left and 20% only right ventricular disease. 
Abdominal distension with abdominal pain was seen in all 
patients. Two patients had abdominal distension without 
fluid. All others had ascites. Nineteen patients had a 
pericardial effusion (53%). Minor pedal oedema were 
seen in 8 patients (22.2%), and none had gross oedema 
Mean ascitic total protein was 3.2gm/dl (0.7 to 7.9 gm/
dl) and albumin 1.5 gm/dl (0.2 to 3.5gm/dl). According 
to total protein content ascites was classified in 75% as 
exudative. 
Figure 1a. Ascites lateral view Figure 2. Raised jugular venous pressure Figure 1b. Hepatosplenomegaly 
Table 2. Frequency and density of various deposits seen 
in peritoneal biopsies from 26 EMF patients 
Cell type Frequency Density
n % mild moderate marked
Russel bodies+ 13 50 5 4 4
Fibrin** 13 50 5 6 2
Haemosiderin** 8 32 3 3 2
*Densities according to number of +Russel bodies seen in the biopsy: 
mild=1-4, moderate=5-9, marked=10+; 
**fraction of biopsy tissue showing fibrin or staining for haemosiderin 
pigment, respectively: mild= <1/3, moderate=>1/3, marked=>2/3. 
Density according to number of cells in high power fields: mild=1-4, 
moderate=5-9, marked=10+.




All peritoneal biopsies showed varying degrees of 
fibrosis. Fifty per cent showed activated mesothelial cells, 
and in one case fibrosis was the only other change.
Ninety three per cent of the patients (N=26) showed 
mild or moderate inflammatory changes indicative of 
chronic peritonitis. Severe inflammation with dense 
infiltrates were not seen. Lymphocytes predominated. 
Plasma cells and eosinophils were less common. 
Neutrophils were not seen (Table 1). All three cellular 
components were found in only three patients. Seven 
patients showed two cell types. Lymphocytes alone were 
most commonly seen and showed marked variation in 
density. In two samples the cells were focally numerous 
and formed lymphoid aggregates. Plasma cells and 
eosinophils were present mainly in mild infiltrates. Mild 
vascularisation was noted in 88% showing an increase in 
capillaries or formation of granulation tissue. This tended 
to be associated with lymphocytic infiltrates.
Other components of inflammation were seen in the 
form of Russel bodies, fibrin and haemosiderin pigment 
in frequencies and graded densities not very different 
from each other (Table 2). Their respective frequencies 
were 50%, 50% and 32%, and they were distributed in 
the tissue with densities ranging from mild to severe. 
Peritoneal biopsies from 11 controls showed several 
types of tissue, namely fascial and adipose tissue, mostly 
covered by a serosal lining with a collagenous band, and 
striated muscle. These tissues appeared to be normal with 
no features similar to those in the EMF group. 
Discussion
This first report of the peritoneal histology of EMF 
patients suggests that the exudative nature of ascitic 
fluid found in this condition may be as a result of an 
inflammatory process. Lymphocytes, plasma cells, deposits 
of fibrin and activated mesothelial cells are features similar 
to those in synovial tissues in non-active rheumatoid 
arthritis. Additional findings not seen in other types of 
peritonitis are mild eosinophilia, high content of Russel 
bodies indicating hypersecretion of immunoglobulins, 
frequent deposits of haemosiderin pigment and marked 
fibrosis. There is also concomitant vascularisation often 
seen in many other types of inflammation. 
Inflammation may account for abdominal pain and 
distension, which are frequently observed in EMF patients 
even before the appearance of ascites. It may also explain 
the marked ascites and lack of pedal oedema observed even 
in pure left ventricular disease. There are other reports 
of extra-cardiac lesions in EMF. An immunofluorescent 
study on autopsy material showed fibrin in a number of 
organs, which were not seen in tissues from cases with 
myocardial infarction and hypertensive heart disease 
[10]. Small granulomata were detected in the liver in 
a high proportion of cases [11]. The high frequency of 
pericardial effusions suggests that inflammatory processes 
may affect the pericardium as well as the peritoneum and 
other serosal membranes [7].  Moreover, fibrosis may be 
seen not only in the heart and peritoneum but also in 
skeletal muscle. It is possible, therefore, that EMF could 
be a widespread systemic disease, and not just confined to 
the heart [12]. 
Fibrosis and associated fibrin deposits may impair 
the resorptive capacity of the peritoneum and hence 
explain the failure of diuretics to reduce ascites. Looking 
for signs of abdominal inflammation and fibrosis might 
not only be of diagnostic assistance in early EMF where 
echocardiographic findings are still equivocal, but could 
also lead to a more appropriate therapy with anti-
inflammatory drugs. Anecdotal reports suggest that the 
use of anti-inflammatory therapy late in the course of the 
disease reduces the number of abdominal paracentesis 
required to alleviate abdominal discomfort. Such 
Figure 3. A mixed cellular infiltrate of 
lymphocytes, eosinophils and plasma cells. 
Russel bodies are distinct in the right lower 
corner,and there is concomitant increase in 
vascularisation (H&E, objective x 20)
Figure 4. Serosal lining with 
activated mesothelial cells over 
area with chronic inflammation 
and fibrosis (H&E, objective x 10). 
Figure 5. Marked deposits of fibrin (red) and 
haemosiderin pigment (blue; Prussian blue)
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treatment, if prescribed early in the disease process when 
there is little or no echocardiographically visible cardiac 
involvement might delay or even prevent progression to 
irreversible cardiac damage. A controlled trial of anti-
inflammatory therapy is needed to test this hypothesis.
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